Tenaya CMO granted 293K options, 49K RSUs
Tenaya Therapeutics’ chief medical officer received new option and RSU awards as part of equity compensation, increasing directly held and unvested share interests.
Rhea-AI Filing Summary
Tenaya Therapeutics, Inc. (TNYA) reported that Chief Medical Officer Tingley Whittemore received equity awards on September 10, 2026. These include a stock option for 293,000 shares of common stock at an exercise price of $0.6488 per share, vesting monthly over four years, and 49,000 restricted stock units vesting in semiannual installments starting February 15, 2027. Following the RSU grant, Whittemore directly holds 263,073 shares of common stock, including 142,076 shares subject to RSU vesting. No Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 342,000 shares
Grant/Award
2 txns
Insider
Tingley Whittemore
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to buy) F4 | 293,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1, F2, F3 | 49,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to buy) — 293,000 contracts (Direct);
Common Stock — 263,073 shares (Direct)
Footnotes (4)
- F1. Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock.
- F2. The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. Amended and Restated 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on February 15, 2027, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested.
- F3. Includes 142,076 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- F4. Option granted pursuant to the Tenaya Therapeutics, Inc. Amended and Restated 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested.
Key Figures
Stock options granted: 293,000 shares
Option exercise price: $0.6488 per share
Option expiration date: September 9, 2036
+4 more
7 metrics
Stock options granted
293,000 shares
Option to buy Tenaya Therapeutics common stock granted September 10, 2026
Option exercise price
$0.6488 per share
Exercise price for 293,000-share stock option grant
Option expiration date
September 9, 2036
Expiration of stock option granted to Chief Medical Officer
Restricted stock units granted
49,000 units
RSUs granted September 10, 2026 under 2021 Equity Incentive Plan
Vesting start for RSUs
February 15, 2027
First 1/8 of RSU award vests on this date
Shares held after transaction
263,073 shares
Total common stock directly held by Whittemore after RSU grant
Unvested RSU component included in holdings
142,076 shares
Common shares to be issued upon vesting of existing restricted stock units
Key Terms
restricted stock units, Amended and Restated 2021 Equity Incentive Plan, vesting, exercise price
4 terms
restricted stock units financial
"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Amended and Restated 2021 Equity Incentive Plan financial
"granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. Amended and Restated 2021 Equity Incentive Plan."
vesting financial
"The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion_or_exercise_price": "0.6488""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did TNYA grant to Chief Medical Officer Tingley Whittemore?
Whittemore received a stock option for 293,000 shares of Tenaya Therapeutics common stock at an exercise price of $0.6488 per share and 49,000 restricted stock units, both granted on September 10, 2026 as part of equity compensation.
What are the vesting terms of the new stock option granted by TNYA?
The option for 293,000 shares was granted under the Amended and Restated 2021 Equity Incentive Plan and will vest as to 1/48th of the shares each month starting one month after September 10, 2026, until fully vested, with expiration on September 9, 2036.
How do the restricted stock units granted by TNYA to Whittemore vest?
The 49,000 restricted stock units granted on September 10, 2026 vest as to 1/8 of the total shares on February 15, 2027 and 1/8 every six months thereafter until the award is fully vested.
Were Whittemore’s TNYA equity awards made under a Rule 10b5-1 trading plan?
No. The filing shows the Rule 10b5-1 checkbox as not checked, and there is no footnote indicating that these equity awards were made under a Rule 10b5-1 or other pre-arranged trading plan.
What is the exercise price and term of Whittemore’s new TNYA stock option?
The new stock option covers 293,000 shares of common stock at an exercise price of $0.6488 per share. It begins vesting one month after September 10, 2026 and expires on September 9, 2036, if not earlier exercised or forfeited.
AI-generated analysis. How Rhea-AI works. Not financial advice.
